Diabetic Kidney Disease: A Report From an ADA Consensus Conference von Tuttle, Katherine R., MD, Bakris, George L., MD, Bilous, Rudolf W., MD, Chiang, Jane L., MD, de Boer, Ian H., MD, Goldstein-Fuchs, Jordi, DSc, APRN, RD, Hirsch, Irl B., MD, Kalantar-Zadeh, Kamyar, MD, MPH, PhD, Narva, Andrew S., MD, Navaneethan, Sankar D., MD, MPH, Neumiller, Joshua J., PharmD, Patel, Uptal D., MD, Ratner, Robert E., MD, Whaley-Connell, Adam T., DO, MSPH, Molitch, Mark E., MD

Volltext

Hypoglycemia: New Definitions and Regulatory Implications von Ratner, Robert E

Volltext

Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis von Skyler, Jay S, Bakris, George L, Bonifacio, Ezio, Darsow, Tamara, Eckel, Robert H, Groop, Leif, Groop, Per-Henrik, Handelsman, Yehuda, Insel, Richard A, Mathieu, Chantal, McElvaine, Allison T, Palmer, Jerry P, Pugliese, Alberto, Schatz, Desmond A, Sosenko, Jay M, Wilding, John P H, Ratner, Robert E

Volltext

Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association von Insel, Richard A, Dunne, Jessica L, Atkinson, Mark A, Chiang, Jane L, Dabelea, Dana, Gottlieb, Peter A, Greenbaum, Carla J, Herold, Kevan C, Krischer, Jeffrey P, Lernmark, Åke, Ratner, Robert E, Rewers, Marian J, Schatz, Desmond A, Skyler, Jay S, Sosenko, Jay M, Ziegler, Anette-G

Volltext

Diabetic kidney disease: a report from an ADA Consensus Conference von Tuttle, Katherine R, Bakris, George L, Bilous, Rudolf W, Chiang, Jane L, de Boer, Ian H, Goldstein-Fuchs, Jordi, Hirsch, Irl B, Kalantar-Zadeh, Kamyar, Narva, Andrew S, Navaneethan, Sankar D, Neumiller, Joshua J, Patel, Uptal D, Ratner, Robert E, Whaley-Connell, Adam T, Molitch, Mark E

Volltext

SGLT Inhibitors for Type 1 Diabetes: Proceed With Extreme Caution von Wolfsdorf, Joseph I, Ratner, Robert E

Volltext

Metformin Should Be Used to Treat Prediabetes in Selected Individuals von Herman, William H., Ratner, Robert E.

Volltext

Prevention of Type 2 Diabetes in Women With Previous Gestational Diabetes von Ratner, Robert E

Volltext

1245-P: Outcomes among Veterans with T2D at Time of Departure from Virtual Clinic: A Nationwide, Real World Study von FELL, BRANDON, VANTIEGHEM, MICHELLE, MCKENZIE, AMY L., RATNER, ROBERT E.

Volltext

834-P: Two-Year Effects of Carbohydrate-Restricted Nutrition Therapy Delivered via Continuous Remote Care among Veterans with Type 2 Diabetes: A Nationwide, Real-World Study von MCKENZIE, AMY L., VANTIEGHEM, MICHELLE, FELL, BRANDON, RATNER, ROBERT E.

Volltext

932-P: Impact of Carbohydrate-Restricted Nutrition Therapy Delivered via Continuous Remote Care on Prevalence of Glycemic Target Achievement and Type 2 Diabetes Remission among Vet... von MCKENZIE, AMY L., VANTIEGHEM, MICHELLE, FELL, BRANDON, RATNER, ROBERT E.

Volltext

29-OR: Impact of Carbohydrate-Restricted Nutrition Therapy Delivered via Continuous Remote Care on Metabolic Markers in Veterans with Type 2 Diabetes: A Nationwide, Real-World Stud... von VANTIEGHEM, MICHELLE, MCKENZIE, AMY L., RATNER, ROBERT E.

Volltext

The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: the "gift" that keeps on giving von Cefalu, William T, Ratner, Robert E

Volltext

COVID-19 in People With Diabetes: Urgently Needed Lessons From Early Reports von Riddle, Matthew C., Buse, John B., Franks, Paul W., Knowler, William C., Ratner, Robert E., Selvin, Elizabeth, Wexler, Deborah J., Kahn, Steven E.

Volltext

Effects of Exenatide (Exendin-4) on Glycemic Control and Weight Over 30 Weeks in Metformin-Treated Patients With Type 2 Diabetes von DeFronzo, Ralph A, Ratner, Robert E, Han, Jenny, Kim, Dennis D, Fineman, Mark S, Baron, Alain D

Volltext

Prevention of Diabetes in Women with a History of Gestational Diabetes: Effects of Metformin and Lifestyle Interventions von Ratner, Robert E., Christophi, Costas A., Metzger, Boyd E., Dabelea, Dana, Bennett, Peter H., Pi-Sunyer, Xavier, Fowler, Sarah, Kahn, Steven E.

Volltext

Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial von Garber, Alan, Dr, Henry, Robert, MD, Ratner, Robert, MD, Garcia-Hernandez, Pedro A, MD, Rodriguez-Pattzi, Hiromi, MD, Olvera-Alvarez, Israel, MD, Hale, Paula M, PhD, Zdravkovic, Milan, MD, Bode, Bruce, MD

Volltext

Advancing Basal Insulin Replacement in Type 2 Diabetes Inadequately Controlled With Insulin Glargine Plus Oral Agents: A Comparison of Adding Albiglutide, a Weekly GLP-1 Receptor A... von ROSENSTOCK, Julio, FONSECA, Vivian A, LEITER, Lawrence A, GROSS, Jorge L, RATNER, Robert E, AHREN, Bo, CHOW, Francis C. C, YANG, Fred, MILLER, Diane, JOHNSON, Susan L, STEWART, Murray W

Volltext

Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance von DeFronzo, Ralph A, Tripathy, Devjit, Schwenke, Dawn C, Banerji, MaryAnn, Bray, George A, Buchanan, Thomas A, Clement, Stephen C, Henry, Robert R, Hodis, Howard N, Kitabchi, Abbas E, Mack, Wendy J, Mudaliar, Sunder, Ratner, Robert E, Williams, Ken, Stentz, Frankie B, Musi, Nicolas, Reaven, Peter D

Volltext

We can change the natural history of type 2 diabetes von Phillips, Lawrence S, Ratner, Robert E, Buse, John B, Kahn, Steven E

Volltext